Pfizer and the American Cancer Society have come together to launch “Change the Odds: Uniting to Improve Cancer Outcomes,” a new three-year initiative to bridge the gap in cancer care disparities.

"Change the Odds" aims to enhance awareness of and access to cancer screening, clinical trial opportunities and support in medically underrepresented communities across the United States. The initiative will initially focus on breast and prostate cancer, as they are the most common types of cancer diagnosed among women and men in the United States, respectively, with potential to expand to additional cancer types in the future.

For more information about "Change the Odds" please visit cancer.org/ChangeTheOdds.